¼¼°èÀÇ Ç÷¾× ºÐ¼®±â ¹× ½Ã¾à ½ÃÀå : Á¦Ç°º°, »ç¿ë À¯Çüº°, °¡°Ýº°, ¿ëµµº°, ÃÖÁ¾»ç¿ëÀÚº°, Áö¿ªº°(2025-2033³â)
Hematology Analyzers and Reagents Market Report by Product, Usage Type, Price Range, Application, End User, and Region 2025-2033
»óǰÄÚµå : 1675305
¸®¼­Ä¡»ç : IMARC Group
¹ßÇàÀÏ : 2025³â 03¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 147 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 2,999 £Ü 4,221,000
PDF & Excel (Single User License) help
PDF, Excel º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμâ´Â 1ȸ °¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 3,999 £Ü 5,628,000
PDF & Excel (5 User License) help
PDF, Excel º¸°í¼­¸¦ µ¿ÀÏ »ç¾÷ÀåÀÇ 5¸í±îÁö ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμâ´Â °¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 4,999 £Ü 7,036,000
PDF & Excel (Corporate License) help
PDF, Excel º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμâ´Â °¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


¤± Add-on °¡´É: °í°´ÀÇ ¿äû¿¡ µû¶ó ÀÏÁ¤ÇÑ ¹üÀ§ ³»¿¡¼­ CustomizationÀÌ °¡´ÉÇÕ´Ï´Ù. ÀÚ¼¼ÇÑ »çÇ×Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

Çѱ۸ñÂ÷

Ç÷¾× ºÐ¼®±â ¹× ½Ã¾à ½ÃÀå ¼¼°è ½ÃÀå ±Ô¸ð´Â 2024³â 93¾ï ´Þ·¯¿¡ ´ÞÇß½À´Ï´Ù. ÇâÈÄ IMARC GroupÀº 2033³â¿¡´Â 157¾ï ´Þ·¯¿¡ ´ÞÇϰí, 2025-2033³â ¿¬Æò±Õ ¼ºÀå·ü(CAGR)Àº 5.64%¸¦ ³ªÅ¸³¾ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ÀÌ ½ÃÀåÀº Ç÷¾× Áúȯ ¹× ¸¸¼º ÁúȯÀÇ ÀÌȯÀ² Áõ°¡, Ç÷¾×ÇÐ ºÐ¼® ÀåºñÀÇ ±â¼ú ¹ßÀü, Àü ¼¼°è ³ëÀÎ Àα¸ Áõ°¡, ÇöÀå Áø´Ü(POC)¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡, Áø´Ü¿¡ ÀΰøÁö´É(AI)°ú ¸Ó½Å·¯´×(ML)ÀÇ ÅëÇÕ¿¡ ÀÇÇØ ÁÖµµµÇ°í ÀÖ½À´Ï´Ù.

Ç÷¾× ºÐ¼®±â ¹× ½Ã¾àÀº Ç÷¾× »ùÇÃÀ» Á¤È®Çϰí È¿À²ÀûÀ¸·Î Æò°¡ÇÒ ¼ö ÀÖ°Ô ÇØÁÖ¸ç, Çö´ë ÀÇ·á Áø´Ü¿¡¼­ Áß¿äÇÑ ¿ªÇÒÀ» Çϰí ÀÖ½À´Ï´Ù. À̵éÀº ´Ù¾çÇÑ Ç÷¾× ¸Å°³ º¯¼ö¸¦ ºÐ¼®Çϰí ȯÀÚÀÇ °Ç°­ »óÅ¿¡ ´ëÇÑ ±ÍÁßÇÑ ÅëÂû·ÂÀ» Á¦°øÇϵµ·Ï ¼³°èµÇ¾ú½À´Ï´Ù. Ç÷¾× ºÐ¼®±â´Â »ùÇà ó¸® ½Ã½ºÅÛ, À¯Ã¼ ½Ã½ºÅÛ, ¼¼Æ÷ °è¼ö ¹× ºÐÈ­ ½Ã½ºÅÛ, µ¥ÀÌÅÍ Ã³¸® ÀåÄ¡ µî ¸î °¡Áö ÁÖ¿ä ±¸¼º ¿ä¼Ò·Î ±¸¼ºµË´Ï´Ù. ÀÌ·¯ÇÑ ºÐ¼®±â¿Í ÇÔ²² »ç¿ëµÇ´Â ½Ã¾àÀº ƯÁ¤ Ç÷¾× ¼ººÐÀÇ °ËÃâ ¹× ÃøÁ¤À» ¿ëÀÌÇÏ°Ô ÇÕ´Ï´Ù. Ç÷¾×ÇÐ ºÐ¼®±â´Â ÀÓ»ó ÇöÀå¿¡¼­ ¸î °¡Áö ÀåÁ¡ÀÌ ÀÖ½À´Ï´Ù. ºü¸¥ °á°ú¸¦ ¾òÀ» ¼ö ÀÖ¾î Àû½Ã¿¡ Áø´Ü ¹× Ä¡·á ¹æÄ§À» °áÁ¤ÇÒ ¼ö ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ³ôÀº Á¤¹Ðµµ¿Í Á¤È®µµ¸¦ °®Ãß°í ÀÖ¾î Áø´Ü ¿À·ùÀÇ À§ÇèÀ» ÃÖ¼ÒÈ­ÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀüÇ÷±¸°è»ê(CBC), ¹éÇ÷±¸ °¨º°, Çì¸ð±Û·Îºó ¼öÄ¡ µî ´Ù¾çÇÑ Ç÷¾× ÆÄ¶ó¹ÌÅ͸¦ ºÐ¼®ÇÒ ¼ö ÀÖ½À´Ï´Ù. ÇöÀç ¼ÒÇü Ź»óÇüºÎÅÍ ´ëÇü ÀüÀÚµ¿ ½Ã½ºÅÛ±îÁö ´Ù¾çÇÑ À¯ÇüÀÇ Ç÷¾× ºÐ¼®±â°¡ ÆÇ¸ÅµÇ°í ÀÖ½À´Ï´Ù.

Ç÷¾× ºÐ¼®±â ¹× ½Ã¾à ½ÃÀå µ¿Çâ :

¼¼°è Ç÷¾× ºÐ¼®±â ¹× ½Ã¾à ½ÃÀåÀº ÁÖ·Î ºóÇ÷, ¹éÇ÷º´, Ç÷¿ìº´°ú °°Àº Ç÷¾× ÁúȯÀÇ À¯º´·ü Áõ°¡¸¦ Æ÷ÇÔÇÑ ¸î °¡Áö Áß¿äÇÑ ¿äÀο¡ ÀÇÇØ °¡¼ÓÈ­µÇ°í ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ³ëÀÎ Àα¸ Áõ°¡¿Í Ç÷¾×ÇÐ ºÐ¼® Àåºñ¿¡ ÀΰøÁö´É(AI) ¹× ¸Ó½Å·¯´×(ML) ¾Ë°í¸®ÁòÀÇ ÅëÇÕ°ú °°Àº ±â¼úÀÇ ±Þ¼ÓÇÑ ¹ßÀüÀÌ ½ÃÀå ¼ºÀåÀ» °¡¼ÓÇϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ½Å¼ÓÇϰí Á¤È®ÇÑ °á°ú¸¦ Á¦°øÇÏ´Â ÀÚµ¿ Ç÷¾×ÇÐ ºÐ¼®±âÀÇ ½ÇÇè½Ç ¹× º´¿ø¿¡¼­ÀÇ Ã¤ÅÃÀÌ Áõ°¡Çϰí ÀÖ´Â °Íµµ ½ÃÀå ¼ºÀåÀ» °¡¼ÓÇϰí ÀÖ½À´Ï´Ù. Áúº´ÀÇ Á¶±â ¹ß°ß ¹× ¿¹¹æÀû °Ç°­ °ü¸® Á¶Ä¡ÀÇ Á߿伺¿¡ ´ëÇÑ ÀνÄÀÌ ³ô¾ÆÁö¸é¼­ ÇöÀå °Ë»ç(POCT) ±â±â ¹× ÈÞ´ë¿ë Ç÷¾×ÇÐ ºÐ¼®±â¿¡ ´ëÇÑ ¼ö¿ä°¡ ±ÞÁõÇÏ´Â °Íµµ ½ÃÀå ¼ºÀåÀÇ ¿äÀÎÀ¸·Î ÀÛ¿ëÇϰí ÀÖ½À´Ï´Ù. ÀÌ¿¡ µû¶ó »õ·Î¿î ½Ã¾à ¹× ºÐ¼®±â °³¹ß¿¡ ÁßÁ¡À» µÐ Ç÷¾×ÇÐ ¿¬±¸ °³¹ß(R&D) Ȱµ¿¿¡ ´ëÇÑ ÁöÃâÀÌ ±ÞÁõÇϰí ÀÖÀ¸¸ç, ÀÌ´Â ½ÃÀå ¼ºÀåÀ» °¡¼ÓÇϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ, Á¦Ç° Æ÷Æ®Æú¸®¿À¸¦ °­È­Çϰí Áö¸®Àû ÀÔÁö¸¦ È®´ëÇϱâ À§ÇÑ ÁÖ¿ä ±â¾÷ °£ÀÇ Àü·«Àû Á¦ÈÞ ¹× Çù·Â °ü°èµµ ½ÃÀå ¼ºÀåÀ» °¡¼ÓÇϰí ÀÖ½À´Ï´Ù.

º» º¸°í¼­¿¡¼­ ´Ù·é ÁÖ¿ä Áú¹®

¸ñÂ÷

Á¦1Àå ¼­¹®

Á¦2Àå Á¶»ç ¹üÀ§¿Í Á¶»ç ¹æ¹ý

Á¦3Àå ÁÖ¿ä ¿ä¾à

Á¦4Àå ¼­·Ð

Á¦5Àå ¼¼°èÀÇ Ç÷¾× ºÐ¼®±â ¹× ½Ã¾à ½ÃÀå

Á¦6Àå ½ÃÀå ºÐ¼® : Á¦Ç°º°

Á¦7Àå ½ÃÀå ºÐ¼® : »ç¿ë À¯Çüº°

Á¦8Àå ½ÃÀå ºÐ¼® : °¡°Ýº°

Á¦9Àå ½ÃÀå ºÐ¼® : ¿ëµµº°

Á¦10Àå ½ÃÀå ºÐ¼® : ÃÖÁ¾»ç¿ëÀÚº°

Á¦11Àå ½ÃÀå ºÐ¼® : Áö¿ªº°

Á¦12Àå ¼ºÀå ÃËÁø¿äÀÎ ¹× ¾ïÁ¦¿äÀÎ, ±âȸ

Á¦13Àå ¹ë·ùüÀÎ ºÐ¼®

Á¦14Àå PorterÀÇ Five Forces ºÐ¼®

Á¦15Àå °¡°Ý ºÐ¼®

Á¦16Àå °æÀï ±¸µµ

LSH
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

The global hematology analyzers and reagents market size reached USD 9.3 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 15.7 Billion by 2033, exhibiting a growth rate (CAGR) of 5.64% during 2025-2033. The market is propelled by the rising incidence of blood disorders and chronic illnesses, significant technological advancements in hematology analyzers, rising geriatric population globally, significantly rising demand for point-of-care (POC) diagnostics, and integration of artificial intelligence (AI) and machine learning (ML) in the diagnostics.

Hematology analyzers and reagents play a crucial role in modern medical diagnostics, enabling the accurate and efficient assessment of blood samples. They are designed to analyze various blood parameters and provide valuable insights into a patient's health. Hematology analyzers consist of several key components, including a sample handling system, a fluidics system, a cell counting and differentiation system, and a data processing unit. Reagents used in conjunction with these analyzers help facilitate the detection and measurement of specific blood components. Hematology analyzers offer several advantages in clinical settings, such as they provide rapid results, allowing for timely diagnosis and treatment decisions. Additionally, they offer high levels of accuracy and precision, minimizing the risk of diagnostic errors. They are capable of analyzing a wide range of blood parameters, including complete blood count (CBC), white blood cell differential, and hemoglobin levels. Currently, there are different types of hematology analyzers available, ranging from compact benchtop models to larger, fully automated systems.

Hematology Analyzers and Reagents Market Trends:

The global hematology analyzers and reagents market is primarily accelerated by several key factors, including the rising prevalence of blood disorders, such as anemia, leukemia, and hemophilia. Moreover, the growing geriatric population and rapid advancements in technology, such as the integration of artificial intelligence (AI) and machine learning (ML) algorithms in hematology analyzers, are driving the market growth. Additionally, the increasing adoption of automated hematology analyzers in laboratories and hospitals, which offer rapid and precise results, is propelling the market growth. The escalating awareness about the importance of early disease detection and preventive healthcare measures and the surging demand for point-of-care testing (POCT) devices and portable hematology analyzers are other factors contributing to the market growth. In line with this, the surging expenditure in research and development (R&D) activities in hematology, focusing on the development of novel reagents and analyzers, is fueling the market growth. Furthermore, strategic collaborations and partnerships among key players to enhance their product portfolios and expand their geographical presence are favoring the market growth.

Key Market Segmentation:

Product Insights:

Usage Type Insights:

Price Range Insights:

Application Insights:

End User Insights:

Regional Insights:

Competitive Landscape:

Key Questions Answered in This Report:

Table of Contents

1 Preface

2 Scope and Methodology

3 Executive Summary

4 Introduction

5 Global Hematology Analyzers and Reagents Market

6 Market Breakup by Product

7 Market Breakup by Usage Type

8 Market Breakup by Price Range

9 Market Breakup by Application

10 Market Breakup by End User

11 Market Breakup by Region

12 Drivers, Restraints, and Opportunities

13 Value Chain Analysis

14 Porters Five Forces Analysis

15 Price Analysis

16 Competitive Landscape

Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â